Skip to main content
SpringerLink
Log in

Deficiency of Adenosine Deaminase 2 (DADA2)

  • Chapter
  • First Online:
Auto-Inflammatory Syndromes

  • 994 Accesses

Abstract

Deficiency of adenosine deaminase type 2 (DADA2) is a recently discovered, pathogenetically complex autoinflammatory syndrome with features of autoinflammation, immunodeficiency, and autoimmunity. The disease is highly variable in regard to age at onset, disease severity, and organ involvement but typically presents as a childhood-onset vasculopathy resembling polyarteritis nodosa (PAN). Patients with DADA2 characteristically present with livedo racemosa, purpura, leg ulcers, Raynaud’s phenomenon, and digital necrosis and in more severe cases with peripheral neuropathy, and early-onset hemorrhagic and ischemic strokes. Other symptoms include subcutaneous nodules, recurrent fevers, hepatosplenomegaly, ophthalmologic manifestations, hypertension, musculoskeletal symptoms, marrow failure, and hypogammaglobulinemia. Evaluation of ADA2 enzymatic activity and genetic analysis for CECR1 gene mutations may aid in the diagnosis. Treatment for DADA2 is not yet well established and should be based on the individual presentation and severity of the disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Zhou Q, Yang D, Ombrello AK, et al. Early-onset stroke and vasculopathy associated with mutations in ADA2. N Engl J Med. 2014;370:911–20.

    Article  CAS  Google Scholar 

  2. Navon Elkan P, Pierce SB, Segel R, et al. Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy. N Engl J Med. 2014;370:921–31.

    Article  Google Scholar 

  3. van Montfrans J, Zavialov A, Zhou Q. Mutant ADA2 in vasculopathies. N Engl J Med. 2014;371(5):478.

    Article  Google Scholar 

  4. Bras J, Guerreiro R, Santo GC. Mutant ADA2 in vasculopathies. N Engl J Med. 2014;371(5):478–80.

    Article  Google Scholar 

  5. Van Eyck L, Liston A, Wouters C. Mutant ADA2 in vasculopathies. N Engl J Med. 2014;371(5):480.

    PubMed  Google Scholar 

  6. Garg N, Kasapcopur O, Foster J 2nd, et al. Novel adenosine deaminase 2 mutations in a child with a fatal vasculopathy. Eur J Pediatr. 2014;173(6):827–30.

    Article  Google Scholar 

  7. Adenosine HM, Deficiency D. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. Gene reviews. Seattle: University of Washington; 2006. p. 1993–2018.

    Google Scholar 

  8. Zavialov AV, Yu X, Spillmann D, et al. Structural basis for the growth factor activity of human adenosine deaminase ADA2. J Biol Chem. 2010;285:12367–77.

    Article  CAS  Google Scholar 

  9. Giannelou A, Zhou Q, Kastner DL. When less is more: primary immunodeficiency with an autoinflammatory kick. Curr Opin Allergy Clin Immunol. 2014;14(6):491–500.

    Article  CAS  Google Scholar 

  10. Eltzschig HK, Sitkovsky MV, Robson SC. Purinergic signaling during inflammation. N Engl J Med. 2012;367:2322–33.

    Article  CAS  Google Scholar 

  11. Savic S, McDermott MF. Clinical genetics in 2014: new monogenic diseases span the immunological disease continuum. Nat Rev Rheumatol. 2015;11(2):67–8.

    Article  Google Scholar 

  12. Cronstein BN, Eberle MA, Gruber HE, Levin RI. Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells. Proc Natl Acad Sci U S A. 1991;88(6):2441–5.

    Article  CAS  Google Scholar 

  13. Cronstein B. How does methotrexate suppress inflammation? Clin Exp Rheumatol. 2010;28(5 Suppl 61):S21–3. Epub 2010 Oct 28. Review.

    CAS  PubMed  Google Scholar 

  14. Zavialov AV, Engstrom A. Human ADA2 belongs to a new family of growth factors with adenosine deaminase activity. Biochem J. 2005;391:51–7.

    Article  CAS  Google Scholar 

  15. Belot A, Wassmer E, Twilt M, et al. Mutations in CECR1 associated with a neutrophil signature in peripheral blood. Pediatr Rheumatol Online J. 2014;12:44.

    Article  Google Scholar 

  16. McColl SR, St-Onge M, Dussault AA, et al. Immunomodulatory impact of the A2A adenosine receptor on the profile of chemokines produced by neutrophils. FASEB J. 2006;20(1):187–9.

    Article  CAS  Google Scholar 

  17. Zavialov AV, Garcia E, Glaichenhaus N, et al. Human adenosine deaminase 2 induces differentiation of monocytes into macrophages and stimulates proliferation of T helper cells and macrophages. J Leukoc Biol. 2010;88:279–90.

    Article  CAS  Google Scholar 

  18. Caorsi R, Penco F, Grossi A, Insalaco A, Omenetti A, Alessio M, Conti G, Marchetti F, Picco P, Tommasini A, Martino S, Malattia C, Gallizi R, Podda RA, Salis A, Falcini F, Schena F, Garbarino F, Morreale A, Pardeo M, Ventrici C, Passarelli C, Zhou Q, Severino M, Gandolfo C, Damonte G, Martini A, Ravelli A, Aksentijevich I, Ceccherini I, Gattorno M. Monogenic polyarteritis: the lesson of ADA2 deficiency. Pediatric Rheumatol. 2016;14:51.

    Article  Google Scholar 

  19. Gonzalez Santiago TM, Zavialov A, Saarela J, et al. Dermatologic features of ADA2 deficiency in cutaneous polyarteritis nodosa. JAMA Dermatol. 2015;1.

    Google Scholar 

  20. Hashem H, Kelly SJ, Ganson NJ, Hershfield MS. Deficiency of adenosine deaminase 2 (DADA2), an inherited cause of polyarteritis nodosa and a mimic of other systemic rheumatologic disorders. Curr Rheumatol Rep. 2017;19(11):70.

    Article  Google Scholar 

  21. Sahin S, Adrovic A, Barut K, Ugurlu S, Turanli ET, Ozdogan H, Kasapcopur O. Clinical, imaging and genotypical features of three deceased and five surviving cases with ADA2 deficiency. Rheumatol Int. 2018;38(1):129–36.

    Article  CAS  Google Scholar 

  22. Ozen S, Pistorio A, Lusan SM, et al. EULAR/PRINTO/PRES criteria for Henoch-Schonlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: final classification criteria. Ann Rheum Dis. 2010;69:798–806.

    Article  Google Scholar 

  23. Gonzalez Santiago TM, Zavialov A, Saarela J, Seppanen M, Reed AM, Abraham RS, Gibson LE. Dermatologic features of ADA2 deficiency in cutaneous polyarteritis nodosa. JAMA Dermatol. 2015;151(11):1230–4.

    Article  Google Scholar 

  24. Van Montfrans JM, Hartman EA, Braun KP, et al. Phenotypic variability in patients with ADA2 deficiency due to identical homozygous R169Q mutations. Rheumatology (Oxford). 2016;55(5):902–10.

    Article  Google Scholar 

  25. Batu ED, Karadag O, Taskiran EZ, et al. A case series of adenosine deaminase 2-deficient patients emphasizing treatment and genotype-phenotype correlations. J Rheumatol. 2015;42(8):1532–4.

    Article  CAS  Google Scholar 

  26. Wu S, Xu Z, Liang H. Sneddon’s syndrome: a comprehensive review of the literature. Orphanet J Rare Dis. 2014;9:215.

    Article  Google Scholar 

  27. Bolayir E, Yilmaz A, Kugu N, Erdogan H, Akyol M, Akyuz A. Sneddon’s syndrome: clinical and laboratory analysis of 10 cases. Acta Med Okayama. 2004;58(2):59–65. Review

    PubMed  Google Scholar 

  28. Nanthapisal S, Murphy C, Omoyinmi E, Hong Y, Standing A, Berg S, Ekelund M, Jolles S, Harper L, Youngstein T, Gilmour K, Klein NJ, Eleftheriou D, Brogan PA. Deficiency of adenosine deaminase type 2: a description of phenotype and genotype in fifteen cases. Arthritis Rheumatol. 2016;68:2314–22.

    Article  CAS  Google Scholar 

  29. Brogan P, Eleftheriou D. Vasculitis update: pathogenesis and biomarkers. Pediatr Nephrol. 2018;33(2):187–98. https://doi.org/10.1007/s00467-017-3597-4. Epub 2017 Aug 7. Review.

    Article  Google Scholar 

  30. Fellmann F, Angelini F, Wassenberg J, et al. IL-17 receptor A and adenosine deaminase 2 deficiency in siblings with recurrent infections and chronic inflammation. J Allergy Clin Immunol. 2016;137(4):1189–96.e2. https://doi.org/10.1016/j.jaci.2015.07.053. Epub 2015 Nov 20.

    Article  Google Scholar 

  31. Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised international Chapel Hill consensus conference nomenclature of vasculitides. Arthritis Rheum. 2013;65:1–11.

    Article  CAS  Google Scholar 

  32. Schepp J, Bulashevska A, Mannhardt-Laakmann W, et al. Deficiency of adenosine deaminase 2 causes antibody deficiency. J Clin Immunol. 2016;36(3):179–86.

    Article  CAS  Google Scholar 

  33. Caorsi R, Penco F, Grossi A, Insalaco A, Omenetti A, Alessio M, Conti G, Marchetti F, Picco P, Tommasini A, Martino S, Malattia C, Gallizi R, Podda RA, Salis A, Falcini F, Schena F, Garbarino F, Morreale A, Pardeo M, Ventrici C, Passarelli C, Zhou Q, Severino M, Gandolfo C, Damonte G, Martini A, Ravelli A, Aksentijevich I, Ceccherini I, Gattorno M. ADA2 deficiency (DADA2) as an unrecognised cause of early onset polyarteritis nodosa and stroke: a multicentre national study. Ann Rheum Dis. 2017;76(10):1648–56. Epub 2017 May 18.

    Article  CAS  Google Scholar 

  34. Caorsi R, Omenetti A, Picco P, et al. Long-term efficacy of etanercept in ADA2 deficiency. Pediatr Rheumatol Online J. 2014;12(suppl 1):72.

    Article  Google Scholar 

  35. Nihira H, Nakagawa K, Izawa K, Kawai T, Yasumi T, Nishikomori R, Nambu M, Miyagawa-Hayashino A, Nomura T, Kabashima K, Ito M, Iwaki-Egawa S, Sasahara Y, Nakayama M, Heike T. Fever of unknown origin with rashes in early infancy is indicative of adenosine deaminase type deficiency. Scand J Rheumatol. 2017;30:1–3.

    Google Scholar 

  36. Van Eyck JL, Hershfield MS, Pombal D, et al. Hematopoietic stem cell transplantation rescues the immunologic phenotype and prevents vasculopathy in patients with adenosine deaminase 2 deficiency. J Allergy Clin Immunol. 2015;135(1):283–7.

    Article  Google Scholar 

  37. Schepp J, Proietti M, Frede N, Buchta M, Hübscher K, Rojas Restrepo J, Goldacker S, Warnatz K, Pachlopnik Schmid J, Duppenthaler A, Lougaris V, Uriarte I, Kelly S, Hershfield M, Grimbacher B. Screening of 181 patients with antibody deficiency for deficiency of adenosine deaminase 2 sheds new light on the disease in adulthood. Arthritis Rheumatol. 2017;69(8):1689–700. Epub 2017 Jul 5.

    Article  CAS  Google Scholar 

  38. Collison J. Autoinflammation: stem cell transplantation for DADA2. Nat Rev Rheumatol. 2017.

    Google Scholar 

  39. Hashem H, Kumar AR, Müller I, Babor F, Bredius R, Dalal J, Hsu AP, Holland SM, Hickstein DD, Jolles S, Krance R, Sasa G, Taskinen M, Koskenvuo M, Saarela J, van Montfrans J, Wilson K, Bosch B, Moens L, Hershfield M, Meyts I. Hematopoietic stem cell transplantation rescues the hematological, immunological and vascular phenotype in DADA2. Blood. 2017;130(24):2682–88. https://doi.org/10.1182/blood-2017-07-798660. Epub 2017 Oct 3.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division Head Rheumatology, Children’s Hospital Los Angeles, USC Keck School of Medicine, Los Angeles, CA, USA

    Andreas Reiff

Authors
  1. Andreas Reiff
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. New York University School of Medicine, New York, NY, USA

    Petros Efthimiou

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Reiff, A. (2019). Deficiency of Adenosine Deaminase 2 (DADA2). In: Efthimiou, P. (eds) Auto-Inflammatory Syndromes. Springer, Cham. https://doi.org/10.1007/978-3-319-96929-9_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-96929-9_11

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-96928-2

  • Online ISBN: 978-3-319-96929-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation